Clearlake Capital Group has provided a significant capital infusion for a recapitalization of Entelos in exchange for a majority stake in the company. Entelos' existing investor, Imperium Partners Group, also participated in the recapitalization. Entelos is a provider of in silico modeling and simulation products and services, delivering predictive technologies to the pharmaceutical, healthcare, nutrition and consumer markets.
